Example of Expert Review of Neurotherapeutics format
Recent searches

Example of Expert Review of Neurotherapeutics format Example of Expert Review of Neurotherapeutics format Example of Expert Review of Neurotherapeutics format Example of Expert Review of Neurotherapeutics format Example of Expert Review of Neurotherapeutics format Example of Expert Review of Neurotherapeutics format Example of Expert Review of Neurotherapeutics format Example of Expert Review of Neurotherapeutics format Example of Expert Review of Neurotherapeutics format Example of Expert Review of Neurotherapeutics format Example of Expert Review of Neurotherapeutics format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Expert Review of Neurotherapeutics format Example of Expert Review of Neurotherapeutics format Example of Expert Review of Neurotherapeutics format Example of Expert Review of Neurotherapeutics format Example of Expert Review of Neurotherapeutics format Example of Expert Review of Neurotherapeutics format Example of Expert Review of Neurotherapeutics format Example of Expert Review of Neurotherapeutics format Example of Expert Review of Neurotherapeutics format Example of Expert Review of Neurotherapeutics format Example of Expert Review of Neurotherapeutics format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access ISSN: 14737175 e-ISSN: 17448360

Expert Review of Neurotherapeutics — Template for authors

Publisher: Taylor and Francis
Categories Rank Trend in last 3 yrs
Pharmacology (medical) #38 of 246 up up by 12 ranks
Neurology (clinical) #61 of 343 up up by 6 ranks
Neuroscience (all) #34 of 110 up up by 1 rank
journal-quality-icon Journal quality:
High
calendar-icon Last 4 years overview: 370 Published Papers | 2380 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 21/07/2020
Insights & related journals
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Journal Performance & Insights

  • Impact Factor
  • CiteRatio
  • SJR
  • SNIP

Impact factor determines the importance of a journal by taking a measure of frequency with which the average article in a journal has been cited in a particular year.

3.743

8% from 2018

Impact factor for Expert Review of Neurotherapeutics from 2016 - 2019
Year Value
2019 3.743
2018 3.453
2017 3.692
2016 3.149
graph view Graph view
table view Table view

insights Insights

  • Impact factor of this journal has increased by 8% in last year.
  • This journal’s impact factor is in the top 10 percentile category.

CiteRatio is a measure of average citations received per peer-reviewed paper published in the journal.

6.4

3% from 2019

CiteRatio for Expert Review of Neurotherapeutics from 2016 - 2020
Year Value
2020 6.4
2019 6.2
2018 6.0
2017 5.5
2016 5.0
graph view Graph view
table view Table view

insights Insights

  • CiteRatio of this journal has increased by 3% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

SCImago Journal Rank (SJR) measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

1.187

8% from 2019

SJR for Expert Review of Neurotherapeutics from 2016 - 2020
Year Value
2020 1.187
2019 1.101
2018 1.064
2017 1.006
2016 1.102
graph view Graph view
table view Table view

insights Insights

  • SJR of this journal has increased by 8% in last years.
  • This journal’s SJR is in the top 10 percentile category.

Source Normalized Impact per Paper (SNIP) measures actual citations received relative to citations expected for the journal's category.

1.192

4% from 2019

SNIP for Expert Review of Neurotherapeutics from 2016 - 2020
Year Value
2020 1.192
2019 1.143
2018 0.951
2017 0.844
2016 0.813
graph view Graph view
table view Table view

insights Insights

  • SNIP of this journal has increased by 4% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Related Journals

open access Open Access ISSN: 13556177 e-ISSN: 14697661

Cambridge University Press

CiteRatio: 4.4 | SJR: 1.074 | SNIP: 1.257
open access Open Access ISSN: 1570159X e-ISSN: 18756190
recommended Recommended

Bentham Science

CiteRatio: 10.5 | SJR: 1.955 | SNIP: 1.851
open access Open Access ISSN: 11727047 e-ISSN: 11791934
recommended Recommended

Springer

CiteRatio: 8.6 | SJR: 1.565 | SNIP: 1.775
open access Open Access ISSN: 15284042 e-ISSN: 15346293
recommended Recommended

Springer

CiteRatio: 8.4 | SJR: 1.756 | SNIP: 1.825
Expert Review of Neurotherapeutics

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Taylor and Francis

Expert Review of Neurotherapeutics

Expert Review of Neurotherapeutics provides expert reviews on the use of drugs and medicines in clinical neurology and neuropsychiatry.... Read More

Clinical Neurology

Pharmacology (medical)

General Neuroscience

Medicine

i
Last updated on
21 Jul 2020
i
ISSN
1473-7175
i
Impact Factor
High - 1.006
i
Acceptance Rate
80%
i
Open Access
Yes
i
Sherpa RoMEO Archiving Policy
Green faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
Taylor and Francis Custom Citation
i
Citation Type
Numbered
[25]
i
Bibliography Example
Blonder GE, Tinkham M, Klapwijk TM. Transition from metallic to tunneling regimes in superconducting microconstrictions: Excess current, charge imbalance, and supercurrent conversion. Phys Rev B. 1982; 25(7):4515–4532. Available from: 10.1103/PhysRevB.25.4515.

Top papers written in this journal

open accessOpen access Journal Article DOI: 10.1586/ERN.09.34
Pain catastrophizing: a critical review
Phillip J. Quartana1, Claudia M. Campbell1, Robert R. Edwards2

Abstract:

Pain catastrophizing is conceptualized as a negative cognitive–affective response to anticipated or actual pain and has been associated with a number of important pain-related outcomes. In the present review, we first focus our efforts on the conceptualization of pain catastrophizing, highlighting its conceptual history and p... Pain catastrophizing is conceptualized as a negative cognitive–affective response to anticipated or actual pain and has been associated with a number of important pain-related outcomes. In the present review, we first focus our efforts on the conceptualization of pain catastrophizing, highlighting its conceptual history and potential problem areas. We then focus our discussion on a number of theoretical mechanisms of action: appraisal theory, attention bias/information processing, communal coping, CNS pain processing mechanisms, psychophysiological pathways and neural pathways. We then offer evidence to suggest that pain catastrophizing represents an important process factor in pain treatment. We conclude by offering what we believe represents an integrated heuristic model for use by researchers over the next 5 years; a model we believe will advance the field most expediently. read more read less

Topics:

Pain catastrophizing (71%)71% related to the paper, Chronic pain (59%)59% related to the paper
834 Citations
open accessOpen access Journal Article DOI: 10.1586/ERN.09.20
Transition from acute to chronic postsurgical pain: risk factors and protective factors
Joel Katz1, Ze'ev Seltzer2

Abstract:

Most patients who undergo surgery recover uneventfully and resume their normal daily activities within weeks. Nevertheless, chronic postsurgical pain develops in an alarming proportion of patients. The prevailing approach of focusing on established chronic pain implicitly assumes that information generated during the acute in... Most patients who undergo surgery recover uneventfully and resume their normal daily activities within weeks. Nevertheless, chronic postsurgical pain develops in an alarming proportion of patients. The prevailing approach of focusing on established chronic pain implicitly assumes that information generated during the acute injury phase is not important to the subsequent development of chronic pain. However, a rarely appreciated fact is that every chronic pain was once acute. Here, we argue that a focus on the transition from acute to chronic pain may reveal important cues that will help us to predict who will go on to develop chronic pain and who will not. Unlike other injuries, surgery presents a unique set of circumstances in which the precise timing of the physical insult and ensuing pain are known in advance. This provides an opportunity, before surgery, to identify the risk factors and protective factors that predict the course of recovery. In this paper, the epidemiology of chronic postsurgical pain... read more read less

Topics:

Chronic pain (71%)71% related to the paper, Preventive analgesia (59%)59% related to the paper
View PDF
563 Citations
open accessOpen access Journal Article DOI: 10.1586/14737175.8.11.1703
Cholinergic system during the progression of Alzheimer's disease: therapeutic implications.
Elliott J. Mufson1, Scott E. Counts1, Sylvia E. Perez1, Stephen D. Ginsberg2

Abstract:

Alzheimer's disease (AD) is characterized by a progressive phenotypic downregulation of markers within cholinergic basal forebrain (CBF) neurons, frank CBF cell loss and reduced cortical choline acetyltransferase activity associated with cognitive decline. Delaying CBF neurodegeneration or minimizing its consequences is the m... Alzheimer's disease (AD) is characterized by a progressive phenotypic downregulation of markers within cholinergic basal forebrain (CBF) neurons, frank CBF cell loss and reduced cortical choline acetyltransferase activity associated with cognitive decline. Delaying CBF neurodegeneration or minimizing its consequences is the mechanism of action for most currently available drug treatments for cognitive dysfunction in AD. Growing evidence suggests that imbalances in the expression of NGF, its precursor proNGF and the high (TrkA) and low (p75(NTR)) affinity NGF receptors are crucial factors underlying CBF dysfunction in AD. Drugs that maintain a homeostatic balance between TrkA and p75(NTR) may slow the onset of AD. A NGF gene therapy trial reduced cognitive decline and stimulated cholinergic fiber growth in humans with mild AD. Drugs treating the multiple pathologies and clinical symptoms in AD (e.g., M1 cholinoceptor and/or galaninergic drugs) should be considered for a more comprehensive treatment approach for cholinergic dysfunction. read more read less

Topics:

Cognitive decline (56%)56% related to the paper, Cholinergic (54%)54% related to the paper, Choline acetyltransferase (53%)53% related to the paper, Basal forebrain (52%)52% related to the paper, Neurodegeneration (51%)51% related to the paper
View PDF
432 Citations
Journal Article DOI: 10.1586/ERN.12.63
Internet-based psychological treatments for depression
Robert Johansson1, Gerhard Andersson2

Abstract:

Major depression is highly prevalent, and is associated with high societal costs and individual suffering. Evidence-based psychological treatments obtain good results, but access to these treatments is limited. One way to solve this problem is to provide internet-based psychological treatments, for example, with therapist sup... Major depression is highly prevalent, and is associated with high societal costs and individual suffering. Evidence-based psychological treatments obtain good results, but access to these treatments is limited. One way to solve this problem is to provide internet-based psychological treatments, for example, with therapist support via email. During the last decade, internet-delivered cognitive-behavioral therapy (ICBT) has been tested in a series of controlled trials. However, the ICBT interventions are delivered with different levels of contact with a clinician, ranging from nonexisting to a thorough pretreatment assessment in addition to continuous support during treatment. In this review, the authors have found an evidence for a strong correlation between the degree of support and outcome. The authors have also reviewed how treatment content in ICBT varies among treatments, and how various therapist factors may influence outcome. Future possible applications of ICBT for depression and future research needs are also discussed. read more read less
View PDF
369 Citations
Journal Article DOI: 10.1586/ERN.09.78
The genetics of attention-deficit/hyperactivity disorder.
David Coghill1, Tobias Banaschewski

Abstract:

Attention-deficit/hyperactivity disorder (ADHD) is a complex neurodevelopmental disorder that almost certainly represents the common outcome of multiple causal pathways and it is now generally accepted that genetic factors make a significant contribution to these pathways. Behavioral studies suggest a heritability of approxim... Attention-deficit/hyperactivity disorder (ADHD) is a complex neurodevelopmental disorder that almost certainly represents the common outcome of multiple causal pathways and it is now generally accepted that genetic factors make a significant contribution to these pathways. Behavioral studies suggest a heritability of approximately 0.76. While molecular genetic approaches have identified a range of potential candidate genes, it is now clear that the genetics of ADHD are characterized by a number of genes each of which makes a small but significant contribution to the overall risk. Several genome-wide linkage studies have been conducted and, although there are considerable differences in findings between studies, several regions have been supported across several studies (bin 16.4, 5p13, 11q22-25, 17p11). The contribution of several candidate genes has been supported by meta-analyses (DRD4, DRD5, DAT1, HTR1B and SNAP25). Genome-wide association scans are starting to appear but have not yet had sufficient power to produce conclusive results. Gene-environment interactions, which are as yet relatively understudied, are likely to be of importance in fully understanding the role of genes in ADHD and will be discussed. read more read less

Topics:

Attention deficit hyperactivity disorder (54%)54% related to the paper, Candidate gene (51%)51% related to the paper
348 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Expert Review of Neurotherapeutics.

It automatically formats your research paper to Taylor and Francis formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Expert Review of Neurotherapeutics format uses Taylor and Francis Custom Citation citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

Absolutely not! With our tool, you can freely write without having to focus on LaTeX. You can write your entire paper as per the Expert Review of Neurotherapeutics guidelines and autoformat it.

Yes. The template is fully compliant as per the guidelines of this journal. Our experts at SciSpace ensure that. Also, if there's any update in the journal format guidelines, we take care of it and include that in our algorithm.

Sure. We support all the top citation styles like APA style, MLA style, Vancouver style, Harvard style, Chicago style, etc. For example, in case of this journal, when you write your paper and hit autoformat, it will automatically update your article as per the Expert Review of Neurotherapeutics citation style.

You can avail our Free Trial for 7 days. I'm sure you'll find our features very helpful. Plus, it's quite inexpensive.

Yup. You can choose the right template, copy-paste the contents from the word doc and click on auto-format. You'll have a publish-ready paper that you can download at the end.

A matter of seconds. Besides that, our intuitive editor saves a load of your time in writing and formating your manuscript.

One little Google search can get you the Word template for any journal. However, why do you need a Word template when you can write your entire manuscript on SciSpace, autoformat it as per Expert Review of Neurotherapeutics's guidelines and download the same in Word, PDF and LaTeX formats? Try us out!.

Absolutely! You can do it using our intuitive editor. It's very easy. If you need help, you can always contact our support team.

SciSpace is an online tool for now. We'll soon release a desktop version. You can also request (or upvote) any feature that you think might be helpful for you and the research community in the feature request section once you sign-up with us.

Sure. You can request any template and we'll have it up and running within a matter of 3 working days. You can find the request box in the Journal Gallery on the right sidebar under the heading, "Couldn't find the format you were looking for?".

After you have written and autoformatted your paper, you can download it in multiple formats, viz., PDF, Docx and LaTeX.

To be honest, the answer is NO. The impact factor is one of the many elements that determine the quality of a journal. Few of those factors the review board, rejection rates, frequency of inclusion in indexes, Eigenfactor, etc. You must assess all the factors and then take the final call.

SHERPA/RoMEO Database

We have extracted this data from Sherpa Romeo to help our researchers understand the access level of this journal. The following table indicates the level of access a journal has as per Sherpa Romeo Archiving Policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

The 5 most common citation types in order of usage are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

Our journal submission experts are skilled in submitting papers to various international journals.

After uploading your paper on SciSpace, you would see a button to request a journal submission service for Expert Review of Neurotherapeutics.

Each submission service is completed within 4 - 5 working days.

Yes. SciSpace provides this functionality.

After signing up, you would need to import your existing references from Word or .bib file.

SciSpace would allow download of your references in Expert Review of Neurotherapeutics Endnote style, according to taylor-and-francis guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Expert Review of Neurotherapeutics formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template